LATEST VERSION
DEVELOPING · 9 NOV → 15 NOV 2026 · 7 EDITIONS · 43 OUTLETS

FDA requires rare vision-loss warning for GLP-1 drugs

How this story moved: how many newsrooms carried it at each run, when each one picked it up, how our summary's headline changed, and which figures and names held from the first reports to the latest. Everything here is counted from the coverage; none of it is a judgement of anyone's motives.

OUTLETS CARRYING THE STORY, RUN BY RUN

0 21 43 10 Nov 11 Nov 12 Nov 13 Nov 14 Nov 15 Nov 10 Nov 00:23 UTC · US is requiring weight-loss drug makers to warn about possible loss of eye sight 10 Nov 06:21 UTC · US is requiring weight-loss drug makers to warn about possible loss of eye sight 10 Nov 18:23 UTC · US is requiring weight-loss drug makers to warn about possible loss of eye sight 11 Nov 18:21 UTC · FDA requires rare vision-loss warning for GLP-1 drugs

HOW OUR HEADLINE CHANGED · 1 HEADLINE

  1. 11 Nov, 18:21 UTC

    FDA requires rare vision-loss warning for GLP-1 drugs

WHAT HELD, WHAT CAME LATER

From the first reports to the latest

  • Nothing ran from the first third of the coverage to the last.

Entered the story later

  • Nothing new took hold after the first third.